Logo
Z

Zambon (India) Pvt., Ltd.

Zambon is an Italian company that has been operating in the pharmaceutical and fine chemical industry since 1906. The company is currently run by Elena Zambon who is the daughter of the founder. Headquartered in Bresso, in the Province of Milan, the company has business operations in three continents: Europe, South America and Asia. The company employs approximately 2,600 people in 15 countries and its integrated organisation consists of Zambon Company SpA, the industrial holding company for the group which comprises Zach System (fine chemicals), Zambon SpA (pharmaceuticals) and Z-Cube (Research Venture).
Country/AreaIndia
IndustryManufacturing GeneralManufacturingChemicals
Company website
Company phone+39 3902665241
Established1906
Company Revenue$787,004,000
Number of employees1992
SIC Code28283
NAICS Code32325
Main ProductsPharma Plants/en/group/life-enhancedPharma Leadership & Organization Model/en/uniqueness-and-inclusionEthics and ComplianceZoé FoundationDevelopment in ZambonZach SystemWorking in ZambonVirtual PlantR&D PharmaZambon Pharma
https://www.linkedin.com/company/zambonhttps://twitter.com/zambonpharmahttp://www.facebook.com/museozambonhttps://www.youtube.com/channel/uctibwdy2ge3-pfldm7ax5cghttps://www.instagram.com/zambon1906

Company News

Zambon Presents Results from the Two Phase 3 PROMIS Studies of CMS I-neb in Patients with Non-Cystic Fibrosis Bronchiectasis at World Bronchiectasis Conference 2023
Data show inhalation via the I-neb Adaptive Aerosol Delivery System of colistimethate sodium (CMS) results in reduction of pulmonary exacerbations in non-cystic fibrosis bronchiectasis (NCFB) patients compared to placebo The totality of the evidence from the Phase 3 PROMIS program...
dateJul 18, 2023
Zambon Presents Survey Results Showcasing Humanistic Impact of Bronchiolitis Obliterans Syndrome on Patients in the United States
Key humanistic and economic burdens, including stressors on patients and family members, are highlighted in new study presented at the American Thoracic Society (ATS) 2023 Annual Meeting MILAN and BOSTON, May 23, 2023 /PRNewswire/ -- Zambon, a multinational pharmaceutical company focused...
dateMay 23, 2023
Zambon Announces New Data Highlighting Lifetime Burden of Illness in U.S. Patients with Bronchiolitis Obliterans Syndrome at ISPOR 2023
MILAN and BOSTON, May 8, 2023 /PRNewswire/ -- Zambon, a multinational pharmaceutical company focused on innovating cure and care to improve people's health and the quality of patients' lives, today announced the presentation of data from a health economic outcomes study characterizing the...
Zambon Completes Enrollment in Phase 3 Clinical Development Program Evaluating Liposomal Cyclosporine A for Inhalation (L-CsA-i) in Patients with Bronchiolitis Obliterans Syndrome (BOS)
Pivotal Phase 3 studies consist of BOSTON-1 and BOSTON-2, both designed to evaluate the safety and efficacy of L-CsA-i in patients with BOS following either single or double lung transplantation, respectively Approximately fifty percent of lung transplant patients develop BOS within five...
Zambon to Attend the CHEST Annual Meeting 2022
Company to present findings on underlying reasons and high costs associated with lung re-transplantation during a rapid oral session Zambon to host learning theater on immunopathogenic and clinical considerations in the early diagnosis and management of Bronchiolitis Obliterans Syndrome...
dateOct 14, 2022

Business Info

CINU51397DL2002PTC115876
Registered StateDelhi
Registrar Of CompaniesRoC-Delhi
CategoryCompany limited by Shares
Sub CategoryNon-govt company
Company ClassPrivate
Company StatusActive
Registered Office Address15,CHELMESFORD COUNTRY CLUB GHITORNI NEW DELHI South West Delhi DL IN 110030
Authorized Cap5000000.00
Paidup Capital3643900.00

Web Summary

Q1: What is the address of the company's headquarters?
A1: The exact address of the company's headquarters is not explicitly mentioned in the provided content, but it can be inferred that the company has a presence in multiple countries across Europe and Asia.

Q2: What products does Zambon Pharma offer to patients?
A2: Zambon Pharma is a pharmaceutical multinational company committed to improving patients' lives. The company offers various products, including Active Pharmaceutical Ingredients (API) and advanced intermediates for the pharmaceutical industry.

Q3: In what year was Zambon founded?
A3: According to the provided content, Zambon has been innovating cure and care since 1906.

Q4: What is the name of the company's research venture?
A4: The company's research venture is called ZCUBE (Zambon Research).

Q5: What is the philosophy that guides Zambon's ideas and activities as a company?
A5: Benvivere is the philosophy that guides Zambon's ideas and activities as a company. It emphasizes the importance of both professional and personal growth, improving the quality of life and work of staff.

Q6: Where are Zambon's products available in different countries?
A6: The provided content mentions that Zambon has a presence in multiple countries across Europe and Asia, including Belgium, Italy, Brazil, Portugal, Spain, Netherlands, China, Russia, Colombia, and others.

Q7: What is the name of the scientific center promoted by Zambon?
A7: The Health & Quality Factory is a scientific center that promotes health, science, and innovation. It aims to foster dialogue among industry, researchers, and university, promoting relationships, training, debate, and cultural, social, and scientific growth.

Q8: What is the name of the company's foundation that focuses on education?
A8: The Zoé Foundation is a company foundation that focuses on education, aiming to contribute to the development of knowledge and the exchange of information in the field of health and wellbeing.
Customs Data
As a purchaser
As a Supplier
Disable_icon
Get the Whole details
DisableData_png
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Disable_icon
Get the Whole details
DisableContact_png